[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostic Antibodies Market, Global Outlook and Forecast 2022-2028

August 2022 | 62 pages | ID: D2B5BD7FAE6FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Diagnostic Antibody detection is still the primary approach for confirmation of Lyme borreliosis. Quantitative EIAs (enzyme immune assays) are used as a first-line test with the possibility of supplementary western blotting (WB). Specific antibodies are detectable in serum and in CSF.

This report contains market size and forecasts of Diagnostic Antibodies in Global, including the following market information:

Global Diagnostic Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diagnostic Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diagnostic Antibodies include Aytu BioScience, Inc., Agilent Technologies, Inc., Abbott, Abcam plc., Boehringer Ingelheim International GmbH, Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diagnostic Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diagnostic Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diagnostic Antibodies Market Segment Percentages, by Type, 2021 (%)
  • Monoclonal Antibodies
  • polyclonal Antibodies
  • Recombinant Polyclonal Antibodies
  • Others
Global Diagnostic Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diagnostic Antibodies Market Segment Percentages, by Application, 2021 (%)
  • Hospitals
  • Diagnostic Centre
  • Others
Global Diagnostic Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diagnostic Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diagnostic Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diagnostic Antibodies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Aytu BioScience, Inc.
  • Agilent Technologies, Inc.
  • Abbott
  • Abcam plc.
  • Boehringer Ingelheim International GmbH
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diagnostic Antibodies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diagnostic Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIAGNOSTIC ANTIBODIES OVERALL MARKET SIZE

2.1 Global Diagnostic Antibodies Market Size: 2021 VS 2028
2.2 Global Diagnostic Antibodies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diagnostic Antibodies Players in Global Market
3.2 Top Global Diagnostic Antibodies Companies Ranked by Revenue
3.3 Global Diagnostic Antibodies Revenue by Companies
3.4 Top 3 and Top 5 Diagnostic Antibodies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diagnostic Antibodies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diagnostic Antibodies Players in Global Market
  3.6.1 List of Global Tier 1 Diagnostic Antibodies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diagnostic Antibodies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diagnostic Antibodies Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 polyclonal Antibodies
  4.1.4 Recombinant Polyclonal Antibodies
  4.1.5 Others
4.2 By Type - Global Diagnostic Antibodies Revenue & Forecasts
  4.2.1 By Type - Global Diagnostic Antibodies Revenue, 2017-2022
  4.2.2 By Type - Global Diagnostic Antibodies Revenue, 2023-2028
  4.2.3 By Type - Global Diagnostic Antibodies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diagnostic Antibodies Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Centre
  5.1.4 Others
5.2 By Application - Global Diagnostic Antibodies Revenue & Forecasts
  5.2.1 By Application - Global Diagnostic Antibodies Revenue, 2017-2022
  5.2.2 By Application - Global Diagnostic Antibodies Revenue, 2023-2028
  5.2.3 By Application - Global Diagnostic Antibodies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diagnostic Antibodies Market Size, 2021 & 2028
6.2 By Region - Global Diagnostic Antibodies Revenue & Forecasts
  6.2.1 By Region - Global Diagnostic Antibodies Revenue, 2017-2022
  6.2.2 By Region - Global Diagnostic Antibodies Revenue, 2023-2028
  6.2.3 By Region - Global Diagnostic Antibodies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diagnostic Antibodies Revenue, 2017-2028
  6.3.2 US Diagnostic Antibodies Market Size, 2017-2028
  6.3.3 Canada Diagnostic Antibodies Market Size, 2017-2028
  6.3.4 Mexico Diagnostic Antibodies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diagnostic Antibodies Revenue, 2017-2028
  6.4.2 Germany Diagnostic Antibodies Market Size, 2017-2028
  6.4.3 France Diagnostic Antibodies Market Size, 2017-2028
  6.4.4 U.K. Diagnostic Antibodies Market Size, 2017-2028
  6.4.5 Italy Diagnostic Antibodies Market Size, 2017-2028
  6.4.6 Russia Diagnostic Antibodies Market Size, 2017-2028
  6.4.7 Nordic Countries Diagnostic Antibodies Market Size, 2017-2028
  6.4.8 Benelux Diagnostic Antibodies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diagnostic Antibodies Revenue, 2017-2028
  6.5.2 China Diagnostic Antibodies Market Size, 2017-2028
  6.5.3 Japan Diagnostic Antibodies Market Size, 2017-2028
  6.5.4 South Korea Diagnostic Antibodies Market Size, 2017-2028
  6.5.5 Southeast Asia Diagnostic Antibodies Market Size, 2017-2028
  6.5.6 India Diagnostic Antibodies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diagnostic Antibodies Revenue, 2017-2028
  6.6.2 Brazil Diagnostic Antibodies Market Size, 2017-2028
  6.6.3 Argentina Diagnostic Antibodies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diagnostic Antibodies Revenue, 2017-2028
  6.7.2 Turkey Diagnostic Antibodies Market Size, 2017-2028
  6.7.3 Israel Diagnostic Antibodies Market Size, 2017-2028
  6.7.4 Saudi Arabia Diagnostic Antibodies Market Size, 2017-2028
  6.7.5 UAE Diagnostic Antibodies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Aytu BioScience, Inc.
  7.1.1 Aytu BioScience, Inc. Corporate Summary
  7.1.2 Aytu BioScience, Inc. Business Overview
  7.1.3 Aytu BioScience, Inc. Diagnostic Antibodies Major Product Offerings
  7.1.4 Aytu BioScience, Inc. Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.1.5 Aytu BioScience, Inc. Key News
7.2 Agilent Technologies, Inc.
  7.2.1 Agilent Technologies, Inc. Corporate Summary
  7.2.2 Agilent Technologies, Inc. Business Overview
  7.2.3 Agilent Technologies, Inc. Diagnostic Antibodies Major Product Offerings
  7.2.4 Agilent Technologies, Inc. Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.2.5 Agilent Technologies, Inc. Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Diagnostic Antibodies Major Product Offerings
  7.3.4 Abbott Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.3.5 Abbott Key News
7.4 Abcam plc.
  7.4.1 Abcam plc. Corporate Summary
  7.4.2 Abcam plc. Business Overview
  7.4.3 Abcam plc. Diagnostic Antibodies Major Product Offerings
  7.4.4 Abcam plc. Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.4.5 Abcam plc. Key News
7.5 Boehringer Ingelheim International GmbH
  7.5.1 Boehringer Ingelheim International GmbH Corporate Summary
  7.5.2 Boehringer Ingelheim International GmbH Business Overview
  7.5.3 Boehringer Ingelheim International GmbH Diagnostic Antibodies Major Product Offerings
  7.5.4 Boehringer Ingelheim International GmbH Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.5.5 Boehringer Ingelheim International GmbH Key News
7.6 Bio-Rad Laboratories, Inc.
  7.6.1 Bio-Rad Laboratories, Inc. Corporate Summary
  7.6.2 Bio-Rad Laboratories, Inc. Business Overview
  7.6.3 Bio-Rad Laboratories, Inc. Diagnostic Antibodies Major Product Offerings
  7.6.4 Bio-Rad Laboratories, Inc. Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.6.5 Bio-Rad Laboratories, Inc. Key News
7.7 F. Hoffmann-La Roche Ltd.
  7.7.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.7.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.7.3 F. Hoffmann-La Roche Ltd. Diagnostic Antibodies Major Product Offerings
  7.7.4 F. Hoffmann-La Roche Ltd. Diagnostic Antibodies Revenue in Global Market (2017-2022)
  7.7.5 F. Hoffmann-La Roche Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Diagnostic Antibodies Market Opportunities & Trends in Global Market
Table 2. Diagnostic Antibodies Market Drivers in Global Market
Table 3. Diagnostic Antibodies Market Restraints in Global Market
Table 4. Key Players of Diagnostic Antibodies in Global Market
Table 5. Top Diagnostic Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diagnostic Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diagnostic Antibodies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diagnostic Antibodies Product Type
Table 9. List of Global Tier 1 Diagnostic Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diagnostic Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diagnostic Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diagnostic Antibodies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diagnostic Antibodies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diagnostic Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diagnostic Antibodies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diagnostic Antibodies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diagnostic Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diagnostic Antibodies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diagnostic Antibodies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diagnostic Antibodies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diagnostic Antibodies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diagnostic Antibodies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diagnostic Antibodies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diagnostic Antibodies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diagnostic Antibodies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diagnostic Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diagnostic Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diagnostic Antibodies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diagnostic Antibodies Revenue, (US$, Mn), 2023-2028
Table 30. Aytu BioScience, Inc. Corporate Summary
Table 31. Aytu BioScience, Inc. Diagnostic Antibodies Product Offerings
Table 32. Aytu BioScience, Inc. Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies, Inc. Corporate Summary
Table 34. Agilent Technologies, Inc. Diagnostic Antibodies Product Offerings
Table 35. Agilent Technologies, Inc. Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Diagnostic Antibodies Product Offerings
Table 38. Abbott Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)
Table 39. Abcam plc. Corporate Summary
Table 40. Abcam plc. Diagnostic Antibodies Product Offerings
Table 41. Abcam plc. Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim International GmbH Corporate Summary
Table 43. Boehringer Ingelheim International GmbH Diagnostic Antibodies Product Offerings
Table 44. Boehringer Ingelheim International GmbH Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)
Table 45. Bio-Rad Laboratories, Inc. Corporate Summary
Table 46. Bio-Rad Laboratories, Inc. Diagnostic Antibodies Product Offerings
Table 47. Bio-Rad Laboratories, Inc. Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 49. F. Hoffmann-La Roche Ltd. Diagnostic Antibodies Product Offerings
Table 50. F. Hoffmann-La Roche Ltd. Diagnostic Antibodies Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Diagnostic Antibodies Segment by Type in 2021
Figure 2. Diagnostic Antibodies Segment by Application in 2021
Figure 3. Global Diagnostic Antibodies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diagnostic Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diagnostic Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diagnostic Antibodies Revenue in 2021
Figure 8. By Type - Global Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 12. US Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 16. Germany Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 17. France Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 24. China Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. India Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 30. Brazil Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diagnostic Antibodies Revenue Market Share, 2017-2028
Figure 33. Turkey Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diagnostic Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. Aytu BioScience, Inc. Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies, Inc. Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abcam plc. Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim International GmbH Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bio-Rad Laboratories, Inc. Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche Ltd. Diagnostic Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications